![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 50, 39671-39677, December 15, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cancer Immunology and AIDS, Dana-Farber
Cancer Institute and the Department of Pathology, Harvard Medical
School, Boston, Massachusetts 02115
Retroviral integration is mediated by viral
preintegration complexes (PICs), and human immunodeficiency virus type
1 (HIV-1) PICs treated with high salt lose their in vitro
integration activity. Barrier-to-autointegration factor (BAF) is a host
protein that efficiently restores PIC activity, but the mechanism(s) by
which BAF participates in HIV-1 integration remains largely unknown. Here we developed a gel shift assay to study BAF DNA binding, and
analyzed 14 mutant proteins containing substitutions of conserved residues for binding and PIC reconstitution activities. Although wild-type BAF efficiently bound double-stranded DNA, binding to single-stranded DNA, RNA, or an RNA/DNA hybrid was not detected, suggesting that BAF associates with retroviral cDNA relatively late
during reverse transcription. Although some of the BAF mutant proteins
efficiently bound DNA, others were defective for binding. Mutants that
bound DNA efficiently reconstituted HIV-1 integration, even though in
one case binding was just 0.2% of wild-type BAF. Although misfolded
mutants did not reconstitute integration, a structurally intact DNA
binding-defective mutant displayed partial activity at high BAF
concentration. We therefore conclude that both BAF protein structure
and its DNA binding activity play roles in reconstituting HIV-1
integration in vitro.
Both the Structure and DNA Binding Function of the
Barrier-to-Autointegration Factor Contribute to Reconstitution of
HIV Type 1 Integration in Vitro*
*
This work was supported by National Institutes of Health
Grant AI39394, by funds from the G. Harold and Lelia Y. Mathers
Foundation, and by a gift from the Friends 10.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Cancer
Immunology and AIDS, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115. Tel.: 617-632-4361; Fax: 617-632-3113; E-mail: alan_engelman@dfci.harvard.edu.
This article has been cited by other articles:
![]() |
M.-C. Shun, J. E. Daigle, N. Vandegraaff, and A. Engelman Wild-Type Levels of Human Immunodeficiency Virus Type 1 Infectivity in the Absence of Cellular Emerin Protein J. Virol., January 1, 2007; 81(1): 166 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Nichols, M. S. Wiebe, and P. Traktman The Vaccinia-related Kinases Phosphorylate the N' Terminus of BAF, Regulating Its Interaction with DNA and Its Retention in the Nucleus Mol. Biol. Cell, May 1, 2006; 17(5): 2451 - 2464. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Turlure, G. Maertens, S. Rahman, P. Cherepanov, and A. Engelman A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo Nucleic Acids Res., March 20, 2006; 34(5): 1653 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bengtsson and K. L. Wilson Barrier-to-Autointegration Factor Phosphorylation on Ser-4 Regulates Emerin Binding to Lamin A In Vitro and Emerin Localization In Vivo Mol. Biol. Cell, March 1, 2006; 17(3): 1154 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, I. T. Weber, R. W. Harrison, and J. Leis Identification of Amino Acids in HIV-1 and Avian Sarcoma Virus Integrase Subsites Required for Specific Recognition of the Long Terminal Repeat Ends J. Biol. Chem., February 17, 2006; 281(7): 4173 - 4182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. de Oca, K. K. Lee, and K. L. Wilson Binding of Barrier to Autointegration Factor (BAF) to Histone H3 and Selected Linker Histones Including H1.1 J. Biol. Chem., December 23, 2005; 280(51): 42252 - 42262. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Oz Gleenberg, O. Avidan, Y. Goldgur, A. Herschhorn, and A. Hizi Peptides Derived from the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 as Novel Inhibitors of the Viral Integrase J. Biol. Chem., June 10, 2005; 280(23): 21987 - 21996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mansharamani and K. L. Wilson Direct Binding of Nuclear Membrane Protein MAN1 to Emerin in Vitro and Two Modes of Binding to Barrier-to-Autointegration Factor J. Biol. Chem., April 8, 2005; 280(14): 13863 - 13870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mansharamani, D. R. M. Graham, D. Monie, K. K. Lee, J. E. K. Hildreth, R. F. Siliciano, and K. L. Wilson Barrier-to-Autointegration Factor BAF Binds p55 Gag and Matrix and Is a Host Component of Human Immunodeficiency Virus Type 1 Virions J. Virol., December 15, 2003; 77(24): 13084 - 13092. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Forne, M. Carrascal, L. Martinez-Lostao, J. Abian, J. L. Rodriguez-Sanchez, and C. Juarez Identification of the Autoantigen HB as the Barrier-to-Autointegration Factor J. Biol. Chem., December 12, 2003; 278(50): 50641 - 50644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Priet, J.-M. Navarro, G. Querat, and J. Sire Reversion of the Lethal Phenotype of an HIV-1 Integrase Mutant Virus by Overexpression of the Same Integrase Mutant Protein J. Biol. Chem., May 30, 2003; 278(23): 20724 - 20730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Lin and A. Engelman The Barrier-to-Autointegration Factor Is a Component of Functional Human Immunodeficiency Virus Type 1 Preintegration Complexes J. Virol., April 15, 2003; 77(8): 5030 - 5036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Segura-Totten, A. K. Kowalski, R. Craigie, and K. L. Wilson Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly J. Cell Biol., August 5, 2002; 158(3): 475 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Serhan, N. Jourdan, S. Saleun, P. Moullier, and G. Duisit Characterization of Producer Cell-Dependent Restriction of Murine Leukemia Virus Replication J. Virol., June 5, 2002; 76(13): 6609 - 6617. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dirks and A. D. Miller Many Nonmammalian Cells Exhibit Postentry Blocks to Transduction by Gammaretroviruses Pseudotyped with Various Viral Envelopes, Including Vesicular Stomatitis Virus G Glycoprotein J. Virol., July 15, 2001; 75(14): 6375 - 6383. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |